Skip to content
Review Open access

Advances in protein microarray–based proteomics for gastric cancer applications in biomarker discovery, molecular subtyping, and precision oncology

Sep 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 137 references
Medicine

TL;DR

The principles and major formats of protein microarray technologies and their applications in gastric cancer are summarized and current challenges and future directions for clinical translation are discussed.

Abstract

Gastric cancer remains a major cause of cancer-related mortality worldwide, largely due to late diagnosis and pronounced molecular heterogeneity. Although genomic and transcriptomic studies have advanced understanding of gastric tumor biology, they do not fully capture dynamic changes in protein expression, post-translational modifications, and signaling activity that directly regulate cellular function. High-throughput proteomic technologies, particularly protein microarrays, have emerged as powerful platforms for systematic protein profiling in complex biological samples. These technologies enable the simultaneous quantification of hundreds to thousands of proteins with high sensitivity and minimal sample requirements, supporting both discovery and translational research. Recent applications of protein microarrays in gastric cancer include biomarker discovery for early diagnosis, molecular subtyping, characterization of the tumor microenvironment, and assessment of therapeutic response. Multi-protein biomarker panels and integration with computational approaches have demonstrated improved diagnostic performance compared with conventional single-marker assays. In addition, proteomic profiling has provided insights into key signaling pathways and immune-related mechanisms underlying tumor progression and drug resistance. This review summarizes the principles and major formats of protein microarray technologies and highlights their applications in gastric cancer. Current challenges and future directions for clinical translation are also discussed.

Read PDF

Similar papers

Review Open access Sep 2026

Multi-omics and molecular biomarkers in breast cancer: a comprehensive review of diagnostic, prognostic, and predictive applications.

An overview of recent progress in multi-omics approaches is provided and significant miRNA-, lncRNA-, and exosome-related biomarkers associated with the initiation, progression, and therapeutic response of breast cancer are emphasized.

Kamyar Bagheri, Amirhossein Saberi, Maryam Zand et al. · 0 citations
Open access Sep 2026

Functional proteomic and phosphoproteomic profiling of routine FFPE CNS tumor tissue complements genomic and epigenomic characterization

Genomic and DNA methylation-based analyses have transformed the classification of central nervous system (CNS) tumors by enabling robust molecular diagnosis and subclassification. However, these approaches primarily define tumor identity and do not directly capture the functional state of intracellular signaling networ...

Dennis Friedel, Rhaissa Ribeiro da Silva, Ivan Abdulrazak Ahmed et al. · 0 citations
Open access Sep 2026

Personalized proteomic analysis of human colorectal cancer identifies novel biomarkers associated with tumor progression

This study provided an accurate picture of the proteomic landscapes during the progression of carcinogenesis and identified several potential candidates as new biomarkers for CRC, and highlighted the potential of proteomic technology to elucidate clinically relevant cancer signatures.

Qi Zhang, Wen-Yuan Zhu, Jian-Guo Ji et al. · 0 citations
Review Open access Aug 2026

Advances in Mass Spectrometry-Based Proteomics for Kidney Disease Biomarker Discovery and Clinical Translation.

This review provides a comprehensive overview of MS-based proteomics applications in kidney disease research, covering progress in biomarker identification, pathogenic mechanism interrogation, and clinical translation, and addresses current challenges in clinical applications, including sample heterogeneity, data compl...

Ying-Ying Ling, Fei Cai, Ling Li et al. · 0 citations
#explainable ai Review Aug 2026

Multi-Omics-Driven Insights into Cancer Biology and Therapeutic Targeting

The increasing biological complexity and heterogeneity of cancer have driven a shift in oncology drug discovery from single-target approaches toward system-level strategies capable of capturing multilayered disease regulation. Multi-omics technologies, including genomics, transcriptomics, proteomics, metabolomics, epig...

Deval Koshti, N. Khandale, Jignesh Shah et al. · 0 citations
Open access Sep 2026

Integrated transcriptomic and single cell analyses identify matrix stiffness-related candidate prognostic genes and epithelial dynamics in colorectal cancer

Investigation of MS-related prognostic genes and their potential biological relevance in CRC progression finds potential clues for future studies of CRC prognosis and MS-related tumor biology.

Chang-Feng Li, Hai-Hong Liu, Yao-Ping Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.